Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
UMP HEALTHCARE HOLDINGS LIMITED
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 722)
INTERIM RESULTS ANNOUNCEMENT
FOR THE SIX MONTHS ENDED 31 DECEMBER 2021
The board of directors ("Board") of UMP Healthcare Holdings Limited (the "Company" or "UMP") is pleased to announce the interim results of the Company and its subsidiaries (collectively referred to as the "Group") for the six months ended 31 December 2021 together with the comparative figures for the corresponding period in 2020.
INTERIM RESULTS HIGHLIGHTS | |||||||
Six months ended | |||||||
31 December | |||||||
2021 | 2020 | Increase/ | |||||
HK$'000 | HK$'000 | (decrease) | |||||
(Unaudited) | (Unaudited) | ||||||
(Restated) | |||||||
Continuing operations | |||||||
Revenue | 358,210 | 299,221 | 19.7% | ||||
Profit before tax | 60,155 | 57,083 | 5.4% | ||||
Depreciation and amortisation | 37,603 | 37,970 | (1.0%) | ||||
Discontinued operation | 1,197 | ||||||
Profit/(loss) for the period | (14,519) | 108.2% | |||||
Continuing and discontinued operations | 104,168 | ||||||
EBITDA(1) | 83,358 | 25.0% | |||||
Profit for the period | 50,371 | 32,574 | 54.6% | ||||
Revenue from continuing operations | |||||||
Hong Kong & Macau Corporate | 123,517 | ||||||
Healthcare Solution Services | 121,615 | 1.6% | |||||
Hong Kong & Macau Clinical Healthcare Services | 211,988 | 160,122 | 32.4% | ||||
Mainland China Clinical Healthcare Business | 22,705 | 17,484 | 29.9% | ||||
358,210 | 299,221 | 19.7% | |||||
(1) | EBITDA represents earnings before interest (including interest expenses on lease liabilities), tax, | ||||||
depreciation (including depreciation on right-of-use assets) and amortisation. | |||||||
1
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS
Six months ended 31 December 2021
Six months ended 31 December | |||||||
2021 | 2020 | ||||||
Notes | HK$'000 | HK$'000 | |||||
(Unaudited) | (Unaudited) | ||||||
(Restated) | |||||||
CONTINUING OPERATIONS | |||||||
REVENUE | 5 | 358,210 | 299,221 | ||||
Other income and gains | 5 | 4,278 | 3,832 | ||||
Professional services expenses | (127,297) | (109,674) | |||||
Employee benefit expense | (83,890) | (51,972) | |||||
Property rental and related expenses | (4,637) | (3,913) | |||||
Cost of inventories consumed | (19,946) | (14,801) | |||||
Depreciation and amortisation | (37,603) | (37,970) | |||||
Other expenses, net | (29,245) | (27,018) | |||||
Finance cost | (1,834) | (1,804) | |||||
Share of profits of: | 618 | ||||||
Joint ventures | - | ||||||
Associates | 1,501 | 1,182 | |||||
PROFIT BEFORE TAX | 6 | 60,155 | 57,083 | ||||
Income tax expense | 7 | (10,981) | (9,990) | ||||
PROFIT FOR THE PERIOD FROM | |||||||
CONTINUING OPERATIONS | 49,174 | 47,093 | |||||
Discontinued operation | |||||||
1,197 | |||||||
Profit/(loss) for the period from discontinued operation | 8 | (14,519) | |||||
PROFIT FOR THE PERIOD | 50,371 | 32,574 | |||||
Attributable to: | |||||||
Owners of the Company | 44,661 | ||||||
From continuing operations | 42,694 | ||||||
From discontinued operation | 1,666 | (11,615) | |||||
46,327 | 31,079 | ||||||
Non-controlling interests | 4,044 | 1,495 | |||||
50,371 | 32,574 | ||||||
EARNINGS/(LOSS) PER SHARE | |||||||
ATTRIBUTABLE TO ORDINARY EQUITY | |||||||
HOLDERS OF THE COMPANY | 10 | ||||||
Basic and diluted | HK5.835 cents | ||||||
- Continuing operations | HK5.640 cents | ||||||
- Discontinued operation | HK0.218 cents | HK(1.535) cents | |||||
Total - included discontinued operation | HK6.053 cents | HK4.105 cents | |||||
2
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Six months ended 31 December 2021
Six months ended | |||||
31 December | |||||
2021 | 2020 | ||||
HK$'000 | HK$'000 | ||||
(Unaudited) | (Unaudited) | ||||
(Restated) | |||||
PROFIT FOR THE PERIOD | 50,371 | 32,574 | |||
OTHER COMPREHENSIVE INCOME/(LOSS) | |||||
Other comprehensive income/(loss) that may be | |||||
reclassified to profit or loss in subsequent periods: | |||||
Exchange differences on translation of | |||||
foreign operations | 707 | 2,494 | |||
Release of reserve upon disposal of | |||||
subsidiaries | (1,786) | 1,279 | |||
Net other comprehensive income/(loss) that may be | |||||
reclassified to profit or loss in subsequent periods | (1,079) | 3,773 | |||
Other comprehensive income/(loss) that will not be | |||||
reclassified to profit or loss in subsequent periods: | |||||
Changes in fair value of equity investments designated | |||||
at fair value through other comprehensive income | 3,717 | (2,411) | |||
OTHER COMPREHENSIVE INCOME | |||||
FOR THE PERIOD, NET OF TAX | 2,638 | 1,362 | |||
TOTAL COMPREHENSIVE INCOME | |||||
FOR THE PERIOD | 53,009 | 33,936 | |||
Attributable to: | |||||
Owners of the Company | 48,965 | 32,441 | |||
Non-controlling interests | 4,044 | 1,495 | |||
53,009 | 33,936 | ||||
3
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
31 December 2021
31 December | 30 June | |||
2021 | 2021 | |||
Notes | HK$'000 | HK$'000 | ||
(Unaudited) | (Audited) | |||
NON-CURRENT ASSETS | ||||
Property, plant and equipment | 102,453 | 99,430 | ||
Right-of-use assets | 87,765 | 73,666 | ||
Goodwill | 164,768 | 164,768 | ||
Other intangible assets | 60,767 | 61,681 | ||
Investments in joint ventures | 8,589 | 7,970 | ||
Investments in associates | 12,588 | 4,501 | ||
Financial assets at amortised cost | 11 | 6,385 | 19,025 | |
Investments at fair value through other | ||||
comprehensive income | 12 | 26,967 | 23,603 | |
Deferred tax assets | 1,389 | 1,417 | ||
Deposits | 19,175 | 20,544 | ||
Total non-current assets | 490,846 | 476,605 | ||
CURRENT ASSETS | ||||
Inventories | 10,479 | 9,198 | ||
Trade receivables | 13 | 96,872 | 83,364 | |
Prepayments, other receivables and | ||||
other assets | 30,478 | 18,088 | ||
Financial assets at fair value through | ||||
profit or loss | 31,807 | 27,115 | ||
Financial assets at amortised cost | 11 | 26,613 | 14,046 | |
Amounts due from associates | 17,885 | 3,730 | ||
Amount due from a joint venture | 2,151 | 451 | ||
Amounts due from related companies | 1,894 | 1,220 | ||
Tax recoverable | 69 | 551 | ||
Pledged deposits | 2,393 | 1,893 | ||
Cash and cash equivalents | 259,410 | 293,974 | ||
480,051 | 453,630 | |||
Assets of disposal groups classified as | ||||
held for sale | - | 39,742 | ||
Total current assets | 480,051 | 493,372 | ||
4
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
(CONTINUED) 31 December 2021
31 December | 30 June | ||||
2021 | 2021 | ||||
Notes | HK$'000 | HK$'000 | |||
(Unaudited) | (Audited) | ||||
CURRENT LIABILITIES | 44,243 | ||||
Trade payables | 14 | 62,185 | |||
Other payables and accruals | 86,352 | 64,376 | |||
Amounts due to associates | 117 | - | |||
Amounts due to related companies | 2,269 | 5,618 | |||
Amount due to a joint venture | 875 | 561 | |||
Lease liabilities | 44,368 | 38,731 | |||
Tax payable | 22,088 | 26,848 | |||
Liabilities associated with the disposal groups | 200,312 | 198,319 | |||
- | |||||
classified as held for sale | 24,441 | ||||
Total current liabilities | 200,312 | 222,760 | |||
NET CURRENT ASSETS | 279,739 | 270,612 | |||
TOTAL ASSETS LESS CURRENT | |||||
LIABILITIES | 770,585 | 747,217 | |||
NON-CURRENT LIABILITIES | |||||
46,767 | |||||
Lease liabilities | 39,296 | ||||
Deferred tax liabilities | 12,045 | 12,238 | |||
Provision | 2,631 | 2,627 | |||
Total non-current liabilities | 61,443 | 54,161 | |||
Net assets | 709,142 | 693,056 | |||
EQUITY | |||||
Equity attributable to owners of the | |||||
Company | 775 | ||||
Issued capital | 15 | 775 | |||
Reserves | 668,834 | 638,723 | |||
669,609 | 639,498 | ||||
Non-controlling interests | 39,533 | 53,558 | |||
Total equity | 709,142 | 693,056 | |||
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
UMP Healthcare Holdings Ltd. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2022 08:47:01 UTC.